We are live on ! Find out more
ECM

EagleClaw Capital Management Portfolio holdings

AUM $714M
1-Year Est. Return 24.24%
This Fund
S&P 500
This Quarter Est. Return
-2.3%
1 Year Est. Return
+24.24%
3 Year Est. Return
+96.54%
5 Year Est. Return
+138.84%
10 Year Est. Return
+573.51%
AUM
$435M
AUM Growth
-$20.9M
Cap. Flow
-$549K
Cap. Flow %
-0.13%
Top 10 Hldgs %
34.54%
Holding
144
New
2
Increased
34
Reduced
63
Closed
9

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.57M
2
NVDA icon
NVIDIA
NVDA
+$1.14M
3
DIS icon
Walt Disney
DIS
+$1.08M
4
ARMK icon
Aramark
ARMK
+$525K
5
AMZN icon
Amazon
AMZN
+$442K

Sector Composition

Rank Sector Weight
1 Technology 20.12%
2 Consumer Discretionary 17.42%
3 Healthcare 12.52%
4 Financials 11.93%
5 Industrials 11.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BA icon
26
Boeing
BA
$171B
$5.43M 1.25%
28,365
+55
+0.2% +$11K
V icon
27
Visa
V
$684B
$5.33M 1.22%
24,037
-50
-0.2% -$10.8K
LMT icon
28
Lockheed Martin
LMT
$134B
$5.19M 1.19%
11,750
+200
+2% +$81.1K
BMY icon
29
Bristol-Myers Squibb
BMY
$133B
$4.8M 1.1%
65,672
-600
-0.9% -$40.3K
FDX icon
30
FedEx
FDX
$72.7B
$4.77M 1.1%
20,603
+710
+4% +$167K
TMO icon
31
Thermo Fisher Scientific
TMO
$213B
$4.57M 1.05%
7,735
-250
-3% -$144K
BRK.B icon
32
Berkshire Hathaway Class B
BRK.B
$1.1T
$4.34M 1%
12,304
ORCL icon
33
Oracle
ORCL
$374B
$4.29M 0.99%
51,887
-750
-1% -$60.7K
BAC icon
34
Bank of America
BAC
$435B
$4.05M 0.93%
98,163
-1,150
-1% -$51.9K
CRL icon
35
Charles River Laboratories
CRL
$11.2B
$4.01M 0.92%
14,130
+10,135
+254% +$3.13M
PH icon
36
Parker-Hannifin
PH
$123B
$3.97M 0.91%
+13,995
New +$4.22M
TJX icon
37
TJX Companies
TJX
$174B
$3.93M 0.9%
64,940
+3,250
+5% +$218K
NVO
38
Novo Nordisk
NVO
$208B
$3.82M 0.88%
68,750
-1,900
-3% -$97.5K
SBUX icon
39
Starbucks
SBUX
$120B
$3.79M 0.87%
41,632
+1,740
+4% +$164K
INTC icon
40
Intel
INTC
$455B
$3.56M 0.82%
71,923
+150
+0.2% +$7.43K
MAR icon
41
Marriott International
MAR
$98.3B
$3.48M 0.8%
19,800
-350
-2% -$58.2K
WM icon
42
Waste Management
WM
$90.6B
$3.36M 0.77%
21,205
-175
-0.8% -$26.5K
GEN icon
43
Gen Digital
GEN
$16.4B
$3.35M 0.77%
126,450
+20,450
+19% +$562K
GOOGL icon
44
Alphabet (Google) Class A
GOOGL
$4.36T
$3.33M 0.77%
23,980
-3,160
-12% -$429K
RIO icon
45
Rio Tinto
RIO
$158B
$3.33M 0.76%
41,365
+1,725
+4% +$131K
CAT icon
46
Caterpillar
CAT
$375B
$3.31M 0.76%
14,850
+262
+2% +$54.9K
JNJ icon
47
Johnson & Johnson
JNJ
$618B
$3.24M 0.74%
18,266
-75
-0.4% -$12.8K
HOLX
48
DELISTED
Hologic
HOLX
$3.02M 0.69%
39,250
-2,700
-6% -$194K
PCH
49
DELISTED
PotlatchDeltic
PCH
$2.99M 0.69%
56,775
+425
+0.8% +$23.2K
CI icon
50
Cigna
CI
$73.7B
$2.96M 0.68%
12,342
-224
-2% -$52.4K

Similar funds

EagleClaw Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, EagleClaw Capital Management held 144 positions worth $435M, down 4.6% from $456M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

EagleClaw Capital Management's Q1 2022 filing shows 2 new, 34 increased, 63 reduced and 9 closed positions. Its largest new stake was Parker-Hannifin: 13,995 shares worth $3.97M. The largest sale was Apple, an estimated $2.57M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • EagleClaw Capital Management's largest Q1 2022 buy was Parker-Hannifin: 13,995 shares worth $3.97M.
  • EagleClaw Capital Management added most to Charles River Laboratories in Q1 2022, an estimated $3.13M increase.
  • EagleClaw Capital Management's biggest Q1 2022 reduction was Apple, cutting an estimated $2.57M.
  • EagleClaw Capital Management fully exited Aramark in Q1 2022, selling an estimated $525K.
  • EagleClaw Capital Management's ten largest holdings make up 35% of its $435M portfolio in Q1 2022.
  • EagleClaw Capital Management opened 2 new positions and closed 9 in Q1 2022.
  • EagleClaw Capital Management's portfolio value fell 4.6% quarter-over-quarter to $435M.

Based on EagleClaw Capital Management's 13F filing for Q1 2022, filed 13 May 2022.